These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25473309)

  • 1. Efficacy of long-term milnacipran treatment in patients meeting different thresholds of clinically relevant pain relief: subgroup analysis of a randomized, double-blind, placebo-controlled withdrawal study.
    Mease PJ; Clauw DJ; Trugman JM; Palmer RH; Wang Y
    J Pain Res; 2014; 7():679-87. PubMed ID: 25473309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuing efficacy of milnacipran following long-term treatment in fibromyalgia: a randomized trial.
    Clauw DJ; Mease PJ; Palmer RH; Trugman JM; Wang Y
    Arthritis Res Ther; 2013 Aug; 15(4):R88. PubMed ID: 23953493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships among pain, depressed mood, and global status in fibromyalgia patients: post hoc analyses of a randomized, placebo-controlled trial of milnacipran.
    Arnold LM; Palmer RH; Gendreau RM; Chen W
    Psychosomatics; 2012; 53(4):371-9. PubMed ID: 22677218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial.
    Clauw DJ; Mease P; Palmer RH; Gendreau RM; Wang Y
    Clin Ther; 2008 Nov; 30(11):1988-2004. PubMed ID: 19108787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial.
    Arnold LM; Gendreau RM; Palmer RH; Gendreau JF; Wang Y
    Arthritis Rheum; 2010 Sep; 62(9):2745-56. PubMed ID: 20496365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia.
    Branco JC; Zachrisson O; Perrot S; Mainguy Y;
    J Rheumatol; 2010 Apr; 37(4):851-9. PubMed ID: 20156949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pooled analysis of two randomized, double-blind, placebo-controlled trials of milnacipran monotherapy in the treatment of fibromyalgia.
    Geisser ME; Palmer RH; Gendreau RM; Wang Y; Clauw DJ
    Pain Pract; 2011; 11(2):120-31. PubMed ID: 20642487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program.
    Arnold LM; Bateman L; Palmer RH; Lin Y
    Pediatr Rheumatol Online J; 2015 Jun; 13():27. PubMed ID: 26112278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of switching to milnacipran in fibromyalgia patients with an inadequate response to duloxetine: a phase IV pilot study.
    Bateman L; Palmer RH; Trugman JM; Lin Y
    J Pain Res; 2013; 6():311-8. PubMed ID: 23658494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial.
    Mease PJ; Clauw DJ; Gendreau RM; Rao SG; Kranzler J; Chen W; Palmer RH
    J Rheumatol; 2009 Feb; 36(2):398-409. PubMed ID: 19132781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study.
    Goldenberg DL; Clauw DJ; Palmer RH; Mease P; Chen W; Gendreau RM
    Pain Med; 2010 Feb; 11(2):180-94. PubMed ID: 20002596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term (2-week) effects of discontinuing milnacipran in patients with fibromyalgia.
    Saxe PA; Arnold LM; Palmer RH; Gendreau RM; Chen W
    Curr Med Res Opin; 2012 May; 28(5):815-21. PubMed ID: 22429066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 3-year, open-label, flexible-dosing study of milnacipran for the treatment of fibromyalgia.
    Arnold LM; Palmer RH; Ma Y
    Clin J Pain; 2013 Dec; 29(12):1021-8. PubMed ID: 23446068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of milnacipran on the multidimensional aspects of fatigue and the relationship of fatigue to pain and function: pooled analysis of 3 fibromyalgia trials.
    Mease PJ; Palmer RH; Wang Y
    J Clin Rheumatol; 2014 Jun; 20(4):195-202. PubMed ID: 24847745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Milnacipran combined with pregabalin in fibromyalgia: a randomized, open-label study evaluating the safety and efficacy of adding milnacipran in patients with incomplete response to pregabalin.
    Mease PJ; Farmer MV; Palmer RH; Gendreau RM; Trugman JM; Wang Y
    Ther Adv Musculoskelet Dis; 2013 Jun; 5(3):113-26. PubMed ID: 23858335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study.
    Ahmed M; Aamir R; Jishi Z; Scharf MB
    J Clin Sleep Med; 2016 Jan; 12(1):79-86. PubMed ID: 26414990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of milnacipran on neurocognition, pain, and fatigue in fibromyalgia: a 13-week, randomized, placebo-controlled, crossover trial.
    Kim JL; Rele S; Marks DM; Masand PS; Yerramsetty P; Millet RA; Keefe RS; Patkar AA
    Prim Care Companion CNS Disord; 2013; 15(6):. PubMed ID: 24800123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term maintenance of response across multiple fibromyalgia symptom domains in a randomized withdrawal study of pregabalin.
    Pauer L; Atkinson G; Murphy TK; Petersel D; Zeiher B
    Clin J Pain; 2012 Sep; 28(7):609-14. PubMed ID: 22688598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of milnacipran on clinical pain and hyperalgesia of patients with fibromyalgia: results of a 6-week randomized controlled trial.
    Staud R; Lucas YE; Price DD; Robinson ME
    J Pain; 2015 Aug; 16(8):750-9. PubMed ID: 25998206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longterm therapeutic response to milnacipran treatment for fibromyalgia. A European 1-year extension study following a 3-month study.
    Branco JC; Cherin P; Montagne A; Bouroubi A;
    J Rheumatol; 2011 Jul; 38(7):1403-12. PubMed ID: 21459941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.